Hatice Yasemin Balaban

1996 yılında Hacettepe Tıp Fakültesini (İnglizce) bitirdikten sonra Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalında uzmanlık eğitimine başladı ve 2000 yılında İç Hastalıkları Uzmanı ve 2004 yılında Gastroenteroloji Uzmanı oldu. 2005 yılında Abant İzzet Baysal Üniversitesi Gastroenteroloji Bölümünü kurdu. 2008 yılında doçentlik unvanı aldı ve 2015 yılında ise profesörlüğe yükseltildi.

Kayseri Lisesini birincilikle bitirdi. 2006 yılında European Society of Gastrointesinal Endoscopy (ESGE) bursu ile 2 ay süre ile İtalya’da endoskopi eğitimi aldı. Yurt dışında SCI'ye giren dergilerde yayınlanmış çok sayıda çalışmasına 500'den fazla atıf yapıldı. Yerli ve yabancı birçok derneğin üyesi olup, uluslararası dergilerin danışma kurulunda bulunmaktadır.

Dr. Yasemin H Balaban halen Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları ABD Gastroenteroloji Ünitesinde öğretim üyesi olarak çalışmalarını sürdürmektedir.

1. Shifts in liver biopsy indications and histopathological diagnoses: A report from a tertiary care center in TürkiyeDALKILIÇ Y. E., PARLAR Y. E., ŞİMŞEK C., KİKİ Z., DAĞ O., SÖKMENSÜER C., et al.Hepatology Forum, cilt.7, sa.3, ss.262-268, 2026 (Scopus)
2. No Plaque Detected in the Proper Hepatic Artery: A Comparison with Other Abdominal ArteriesTaşkindere Abbasoğlu T., Abbasoğlu A., Karçaaltincaba M., Balaban H. Y., Tokgözoğlu L., Dağ O., et al.Bratislava Medical Journal, cilt.127, sa.6, ss.2348-2360, 2026 (SCI-Expanded, Scopus)
3. A traditional herbal remedy in liver diseases: Momordica charantia L. (kudret narı/bitter melon)Gunduz D. A., BALABAN H. Y., Caliskan U. K.Hepatology Forum, cilt.7, sa.2, ss.154-162, 2026 (Scopus)
4. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across AsiaTakeuchi Y., Tateishi R., Obi S., Otsuka M., Mochizuki H., Jazag A., et al.Hepatology International, cilt.20, sa.2, ss.373-383, 2026 (SCI-Expanded, Scopus)
5. The role of liver biopsy for the investigation of fever of unknown origin: Insights from a small cohortDALKILIÇ Y. E., KİKİ Z., SÖKMENSÜER C., BALABAN H. Y.Journal of gastrointestinal and liver diseases : JGLD, cilt.35, sa.1, ss.135-136, 2026 (SCI-Expanded, Scopus)
6. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and OutcomesDANIŞ N., DÖNGELLİ H., ÜNEK T., Bacakoğlu A., Turan İ., Karasu A. Z., et al.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.37, sa.4, ss.510-523, 2026 (SCI-Expanded, Scopus, TRDizin)
7. Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapyDilber F., Durak S., Unsal Y., DEMİR M., Yildirim A. E., Ellik Z. M., et al.Hepatology Forum, cilt.7, sa.1, ss.26-31, 2026 (Scopus)
8. The Liver in View of AcupunctureFIRAT A., BALABAN H. Y.CURRENT HEPATOLOGY REPORTS, cilt.24, sa.1, 2025 (ESCI, Scopus)
9. Novel prostaglandin and isoprostane panel for evaluating Wilson's DiseasePolat M. B., Durukan B. M., Israfilov S., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., DAĞ O., et al.TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.50, sa.6, ss.870-877, 2025 (SCI-Expanded, Scopus, TRDizin)
10. Commercial real-time PCR kit results for the detection of Helicobacter pylori and clarithromycin resistance in stool samplesInal N., Sahin T., BALABAN H. Y., ŞİMŞEK C., Simsek H., Akyon Y.INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, cilt.57, 2025 (SCI-Expanded, Scopus)
11. Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in TurkiyeTuran I., Akarca U. S., Aladag M., Harputluoglu M., YILMAZ S., Gencdal G., et al.SCIENTIFIC REPORTS, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
12. Performance Evaluation of Gastroenterology Specific Language Model GastroGPT on Hepatocellular Carcinoma ManagementŞimşek C., Üçdal M. T., Yazarkan Y., Durak M. B., Balaban H. Y.İç Hastalıkları Dergisi, cilt.1, sa.2, ss.1-9, 2025 (Hakemli Dergi)
13. Evaluating the Role of Artificial Intelligence in Making Clinical Decisions for Treating Acute PancreatitisBALABAN H. Y., ÜÇDAL M., DURAK M. B., ŞİMŞEK C.JOURNAL OF CLINICAL MEDICINE, cilt.14, 2025 (SCI-Expanded, Scopus)
14. Cytomegalovirus Management in Solid Organ Transplant RecipientsBALABAN H. Y., KÖKSOY B., ŞENDUR İ.OBM TRANSPLANTATION, cilt.9, 2025 (Scopus)
15. Astroviruses and celiac disease: a preliminary study into potential environmental triggersPOLAT C., ŞAHİN T., ŞİMŞEK C., TEKİN İ. E., İsrafilov S., SÖKMENSÜER C., et al.Acta Medica, 2025 (TRDizin)
16. Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi AnemiaOzkocer C., Visal Okur F. V., Demirbilek H., Altintas B., Cetin N., Kuskonmaz B. B., et al.TURKISH JOURNAL OF HEMATOLOGY, cilt.42, sa.1, ss.15-24, 2025 (SCI-Expanded, Scopus, TRDizin)
17. Muscle Strength and Cardiovascular Health in MASLD: A Prospective StudyKumbaroglu B. F., Balaban Y. H., Duger T.MEDICINA-LITHUANIA, cilt.61, sa.2, 2025 (SCI-Expanded, Scopus)
18. Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia?Ismayilov R., ÖZÜM T., ERSAL DEREGÖZÜ E., Israfilov S., Abdurrahimli N., YALÇIN ÇAKMAKLI G., et al.HEPATOLOGY FORUM, cilt.6, sa.1, ss.11-15, 2025 (ESCI, Scopus, TRDizin)
19. Otoimmün hepatit epidemiyoloji ve patogenezi.ÖZKAN A., BALABAN H. Y.Otoimmün hepatit epidemiyoloji ve patogenezi. Günşar F, editör. Otoimmün Karaciğer Hastalıkları, 2025 (TRDizin)
20. Ribociclib-induced autoimmune-like hepatitis: a case reportKAVGACI G., ŞAHİN T. K., SÖKMENSÜER C., BALABAN H. Y., AKSOY S.JOURNAL OF CHEMOTHERAPY, cilt.37, sa.8, ss.741-746, 2025 (SCI-Expanded, Scopus)
21. Prospective evaluation of patients with non-cirrhotic portal hypertension: A single-centre studyUcdal M., ŞİMŞEK C., Durak B., BALABAN H. Y.ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.60, sa.10, ss.1487-1488, 2024 (SCI-Expanded, Scopus)
22. Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide StudyÜÇBİLEK E., Yildirim A. E., Ellik Z., TURAN İ., HAKTANIYAN B., Orucu B., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.35, sa.10, 2024 (SCI-Expanded, Scopus)
23. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective studyTabak G. H., AKDOĞAN N., DOĞAN GÜNAYDIN S., PARLAR Y. E., BALABAN H. Y., ŞİMŞEK H.ARCHIVES OF DERMATOLOGICAL RESEARCH, cilt.316, sa.5, 2024 (SCI-Expanded, Scopus)
24. Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases.Ayar Ş. N., Aytekin E. S., Şimşek C., Dağ O., Çağdaş D. N., Balaban Y. H.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.35, sa.7, ss.560-567, 2024 (SCI-Expanded, Scopus, TRDizin)
25. Vision for the Journal in the Second Quarter of 21st CenturyBALABAN H. Y., Sheikh Mohammad Fazle A., Mamun A. M.Euroasian journal of hepato-gastroenterology, cilt.14, 2024 (Hakemli Dergi)
26. Selective Immunoglobulin M Deficiency in Patients with Autoimmune Liver DiseasesBalaban Y. H., Ismail M., AYAR Ş. N.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.35, sa.6, ss.505-508, 2024 (SCI-Expanded, Scopus, TRDizin)
27. Evidence-Based Herbal Treatments in Liver DiseasesKarakus M., Altintas D., BALABAN H. Y., Caliskan U. K.Hepatology Forum, cilt.5, sa.1, ss.50-60, 2024 (Scopus, TRDizin)
28. Changing trends in the etiology of liver transplantation in Turkiye: A multicenter studyAkarsu M., DOLU S., Harputluoglu M., YILMAZ S., Akyildiz M., Gencdal G., et al.Hepatology Forum, cilt.5, sa.1, ss.3-6, 2024 (Scopus, TRDizin)
29. Are dietary factors associated with cardiometabolic risk factors in patients with non-alcoholic fatty liver disease?TOPAL G. G., Sevim S., GÜMÜŞ D., BALABAN H. Y., KARÇAALTINCABA M., KIZIL M.PEERJ, cilt.12, 2024 (SCI-Expanded, Scopus)
30. Commercial Real-Time PCR Kit Results for the Detection of Helicobacter pylori and Clarithromycin Resistance in Stool SamplesBALABAN H. Y., İNAL N., ŞİMŞEK C., ŞİMŞEK H., AKYÖN YILMAZ Y.Research Square, 2024 (Hakemli Dergi)
31. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4)Üçdal M. T., Burus A., Celtikci B., Yasemin Balaban H. Y.MEDICAL HYPOTHESES, cilt.181, 2023 (SCI-Expanded, Scopus)
32. Risk of Bleeding After Percutaneous Endoscopic Gastrostomy in Patients Using Antithrombotic DrugsPARLAR Y. E., Mustafayev F., Vahabov C., ŞAHİN T., İsrafilov S., KESKİN O., et al.Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, cilt.33, sa.5, ss.540-542, 2023 (SCI-Expanded, Scopus)
33. Liver immunity, autoimmunity, and inborn errors of immunityPARLAR Y. E., AYAR Ş. N., ÇAĞDAŞ AYVAZ D. N., BALABAN H. Y.World Journal of Hepatology, cilt.15, sa.1, ss.52-67, 2023 (ESCI, Scopus)
34. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver DiseaseYILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.HEPATOLOGY FORUM, cilt.4, ss.1-32, 2023 (ESCI, Scopus, TRDizin)
35. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview Firat A, Abbasoglu TT, Karcaaltincaba M, Balaban YH. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview.FIRAT A., Taşkındere Abbasoğlu T., KARÇAALTINCABA M., BALABAN H. Y.WORLD JOURNAL OF RADIOLOGY, cilt.15, sa.1, ss.1-9, 2023 (Hakemli Dergi)
36. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireviewFIRAT A., TAŞKINDERE ABBASOĞLU T., KARÇAALTINCABA M., Balaban Y. H.WORLD JOURNAL OF RADIOLOGY, cilt.15, sa.1, ss.1-9, 2023 (ESCI)
37. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcomeEfe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Friedrich Staettermayer A., Cengiz M., et al.HEPATOLOGY, cilt.76, sa.6, ss.1576-1586, 2022 (SCI-Expanded, Scopus)
38. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisEfe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.Journal of Autoimmunity, cilt.132, 2022 (SCI-Expanded, Scopus)
39. Characteristics of patients with hepatocellular carcinoma: A multicenter studyGuzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.HEPATOLOGY FORUM, cilt.3, sa.3, ss.71-76, 2022 (ESCI, Scopus, TRDizin)
40. Trends and causes of etiology in adult liver transplant patients: multicenter studyAKARSU M., Harputluoglu M., YILMAZ S., Gencdal G., Akyildiz M., Polat K. Y., et al.JOURNAL OF HEPATOLOGY, cilt.77, 2022 (SCI-Expanded, Scopus)
41. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter studyGÖKCAN H., YAPALI S., Harputluoglu M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.JOURNAL OF HEPATOLOGY, cilt.77, 2022 (SCI-Expanded, Scopus)
42. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional StudyBALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)
43. Abdominal Massage in Functional Chronic Constipation: A Randomized Placebo-Controlled TrialDogan I. G., GÜRŞEN C., AKBAYRAK T., Balaban Y. H., Vahabov C., ÜZELPASACI E., et al.PHYSICAL THERAPY, cilt.102, sa.7, 2022 (SCI-Expanded, Scopus)
44. Practical points that gastrointestinal fellows should know in management of COVID-19ŞAHİN T., ŞİMŞEK C., BALABAN H. Y.WORLD JOURNAL OF CLINICAL CASES, cilt.10, sa.16, ss.5133-5145, 2022 (SCI-Expanded, Scopus)
45. A rare case of DIC in a patient with Wilson's disease: D-penicillaminePARLAR Y. E., BALABAN H. Y., MALKAN Ü. Y., DENİZ E., UYSAL F. R.HEPATOLOGY FORUM, cilt.3, sa.2, ss.61-63, 2022 (ESCI, Scopus, TRDizin)
46. Global multi-stakeholder endorsement of the MAFLD definitionBALABAN H. Y., YILMAZ Y.THE LANCET. GASTROENTEROLOGY & HEPATOLOGY, cilt.7, 2022 (SCI-Expanded, Scopus)
47. Anatomists Should Underline the Geometry of Some Special StructuresFIRAT A., BALABAN H. Y.TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES, cilt.42, sa.2, ss.144-145, 2022 (Scopus, TRDizin)
48. Why Should Anatomists Underline the Geometry of Some Special Structures?FIRAT A., BALABAN H. Y.JOURNAL OF THE ANATOMICAL SOCIETY OF INDIA, cilt.71, sa.2, ss.158-159, 2022 (SCI-Expanded, Scopus)
49. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitisEfe C., Lammert C., Tascilar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.LIVER INTERNATIONAL, cilt.42, sa.3, ss.607-614, 2022 (SCI-Expanded, Scopus)
50. Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant SettingEllik Z. M., İDİLMAN İ. S., Kartal A., Balaban Y., ELHAN A. H., KARÇAALTINCABA M., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.33, sa.2, ss.153-160, 2022 (SCI-Expanded, Scopus, TRDizin)
51. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodiesOzturk O., DEMİRCİ DOS SANTOS DUARTE S., BALABAN H. Y., ŞİMŞEK H., Sener B.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.5, ss.1697-1703, 2022 (SCI-Expanded, Scopus, TRDizin)
52. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULTADANIR H., Etik D. O., YILDIRIM A. E., Mehdiyev S., YAPALI S., COŞAR A. M., et al.HEPATOLOGY, cilt.74, 2021 (SCI-Expanded, Scopus)
53. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULTYAPALI S., GÖKCAN H., Harputluoglu M., Ellik Z. M., AKARSU M., DURAK S., et al.HEPATOLOGY, cilt.74, 2021 (SCI-Expanded, Scopus)
54. Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver TransplantationAKARSU M., ÖNEM S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.9, ss.712-719, 2021 (SCI-Expanded, Scopus)
55. Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2ŞİMŞEK C., Erul E., BALABAN H. Y.WORLD JOURNAL OF CLINICAL CASES, cilt.9, sa.20, ss.5427-5434, 2021 (SCI-Expanded, Scopus)
56. Etiology of Cirrhosis in Turkey: A National Cohort StudyYILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.JOURNAL OF HEPATOLOGY, cilt.75, 2021 (SCI-Expanded, Scopus)
57. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyEfe C., Dhanasekaran R., Lammert C., Ebik B., Higuera-de la Tijera F., Aloman C., et al.HEPATOLOGY, cilt.73, sa.6, ss.2099-2109, 2021 (SCI-Expanded, Scopus)
58. Artificial intelligence method to predict overall survival of hepatocellular carcinomaŞİMŞEK C., GÜVEN D. C., Sahin T. K., TEKİN İ. E., Sahan O., BALABAN H. Y., et al.Hepatology Forum, cilt.2, sa.2, ss.64-68, 2021 (Scopus)
59. Artificial Intelligence to Predict Esophageal Varices in Patients with CirrhosisTEKİN İ. E., ŞİMŞEK C., BALABAN H. Y., ŞAHİN T. K.Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, cilt.12, ss.625-629, 2021 (TRDizin)
60. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinomaAKKIZ H., Carr B. I., GÖZÜKARA BAĞ H. G., KARAOĞULLARINDAN Ü., Yalcin K., Ekin N., et al.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.75, sa.2, 2021 (SCI-Expanded, Scopus)

AVESİS'te 112 kaydın tamamı →

1. Radgohar, A; Burus, A; Ucdal, M; Yalcinkaya, A; Balaban, Y; Celtikci, B. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release. FEBS OPEN BIO. 2025; 15 (Supp2), 450-451Meeting Abstract LB-R-41-07BALABAN H. Y., BURUŞ A., ÜÇDAL M., ÇELTİKÇİ B.FEBS OPEN BIO, Amerika Birleşik Devletleri, 01 Aralık 2025, (Tam Metin Bildiri)
2. MASLD Tanılı Hastalarda Kombine Egzersiz Programının Yaşam Kalitesi Üzerine Etkisi: Erken SonuçlarKUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.19. ULUSLARARASI FİZYOTERAPİDE GELİŞMELER KONGRESİ, Ankara, Türkiye, 09 Nisan 2025, (Özet Bildiri)
3. IS HIGH AFP ASSOCIATED WITH LIVER DISEASES IN AUTOSOMAL RECESSIVE CEREBELLAR ATAXIAS?BALABAN H. Y., YALÇIN ÇAKMAKLI G., ELİBOL B.31st United European Gastroenterology Week 2023, viyana, Avusturya, 12 - 15 Ekim 2023, (Tam Metin Bildiri)
4. Ayar, ŞN., Soyak, E., Şimşek, C., Çağdaş Ayvaz, DN., Balaban, Y. “Otoimmun Karaciğer Hastalarının Primer İmmün Yetmezlik Yönünden Değerlendirilmesi,” 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, SS – 031, 25-29 Kasım 2020.BALABAN H. Y.37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, Türkiye, 25 - 29 Kasım 2020, (Tam Metin Bildiri)
5. Melekoglu Ellik, Z., Idilman, IS., Caliskan KartaL, A., Balaban, YH., karcaaltincaba, M., “Magnetic Resonance Elastography and Transient Elastograpghy to Assess Hepatic Stetaosis and Liver Fibrosis in the Liver Transplant Setting,” Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, NOV 13-16, 2020, ‏Hepatology,Vol. 72, Suppl 1 773A: Abstract 1289, 2020.BALABAN H. Y.Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, 13 - 16 Kasım 2020
6. MAGNETIC RESONANCE ELASTOGRAPHY AND TRANSIENT ELASTOGRAPGHY TO ASSESS HEPATIC STETAOSIS AND LIVER FIBROSIS IN THE LIVER TRANSPLANT SETTINGEllik Z. M., İDİLMAN İ. S., KARTAL A. Ç., Balaban Y. H., KARÇAALTINCABA M., İDİLMAN R.Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri)
7. Hepatitis B virus screening and immunization rates in special risk groups.BALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.World Congress of Gastroenterology 2019, 21 - 24 Eylül 2019, (Özet Bildiri)
8. The efficacy of abdominal massage in functional constipation: A randomized placebo-controlled trialDOĞAN İ. G., ORHAN C., AKBAYRAK T., BALABAN H. Y., VAHABOV C., ÜZELPASACI E., et al.World Congree of Gastroenterology 2019, 21 - 24 Eylül 2019, cilt.30, ss.725-726, (Özet Bildiri)
9. Hepatitis E virus epidemiology of patients with chronic hepatitis C in TurkeyBALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.World Congress of Gastroenterology 2019, 21 - 24 Eylül 2019, (Özet Bildiri)
10. Hepatitis C Awareness Survey: Retrospective Evaluation of HCV Tests between 2000-2017Balaban Y. H., DAĞ O., Alp A., PÜRNAK T., GÖKTAŞ M. A., Tseveldor N., et al.Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
11. Kronik karaciğer hastalarında alfa 1 antitripsin eksikliğiŞİMŞEK H., BALABAN H. Y.7. Ulusal Hepatoloji Kongresi, Türkiye, 01 Ocak 2009
12. Metabolic Syndrome, NASH and Hepatocyte Growth FactorŞİMŞEK H., TATAR G., BALABAN H. Y.13th United European Gastroenterology Week (UEGW), Kopenak, 01 Ocak 2005
13. Is CD26 (Dipeptidyl Peptidase IV) a Novel Candidate For Controlling NASH Pathogenesis?ŞİMŞEK H., TATAR G., BALABAN H. Y.12th United European Gastroenterology Week (UEGW), prag, 01 Ocak 2004
14. Kapsul Endoskopide Klinik Deneyimimiz: 4 Olgunun SunumuŞİMŞEK H., TATAR G., BALABAN H. Y.VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
15. Benign özefagus darliklarinin endoskopik tedavisiŞİMŞEK H., TATAR G., BALABAN H. Y.VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
16. The Screening of Tissue Transglutaminase Antibody in Healty Blood Donors for the Celiac Disease Screening in Turkish PopulationŞİMŞEK H., BALABAN H. Y.4th Congress of European Federation of Internal Medicine, Berlin, Almanya, 01 Ocak 2003
17. Son Bir Yillik ERCP Sonuçlarinin Önceki Yillarla KarşilaştirilmasıŞİMŞEK H., TATAR G., BALABAN H. Y.VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaycan, 01 Ocak 2003
18. Celiac Disease in Turkish PopulationŞİMŞEK H., TATAR G., BALABAN H. Y.4th Congress of European Federation of Internal Medicine, Berlin, Almanya, 01 Ocak 2003
19. Association of Helicobacter Pylori Infection with Familiar Mediterranean Fever DiseaseŞİMŞEK H., BALABAN H. Y.3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 01 Ocak 2002
20. Genotype Screening for Hereditary Hemochromatosis Among Voluntary Blood Donors in TurkeyŞİMŞEK H., BALABAN H. Y.Annual Meeting at Digestive Disease Week (DDW), 01 Ocak 2002
21. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine releaseRADGOHAR A., BURUŞ A., ÜÇDAL M. T., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
22. Fonksiyonel Kabızlıkta Abdominal Masaj ile Birlikte Aerobik Egzersiz Eğitiminin Etkileri: Randomize Kontrollü ÇalışmaDOĞAN İ. G., BALABAN H. Y., AKBAYRAK T., ŞİMŞEK C., ÖZGÜL S.
23. Üniversite Öğrencilerinde Karaciğer Hastalıklarına Yönelik Damgalayıcı TutumlarBALABAN H. Y., TAŞKESEN İ., TAŞKESEN B., güniz Dogan b., ŞİMŞEK C., PARLAR Y. E.
24. Karaciğer Sağlığı Bilgi ve Farkındalık DüzeyiBALABAN H. Y., TAŞKESEN İ., ÇAKMAK M. F., güniz Dogan b., ŞİMŞEK C.
25. THE ROLE OF KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENE VARIANTS IN AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS: ASSOCIATION WITH DISEASE SEVERITY AND DEEP REMISSIONBALABAN H. Y., ÜÇDAL M., BURUŞ A., DAĞ O.
26. PATIENT CHARACTERISTICS OF ADULT CYSTIC FIBROSIS LIVER DISEASE AND THE EFFECTIVENESS OF NONINVASIVE FIBROSIS TESTS IN DETERMINING DISEASE STATUSBALABAN H. Y., KAV T.
27. DIRECT BILIRUBIN-BASED MELD SCORE: IMPACT OF HEPATIC VS. EXTRA-HEPATIC HYPERBILIRUBINEMIA ON STAGING OF CIRRHOSISBALABAN H. Y., ÜÇDAL M., ŞENDUR İ., DAĞ O.
28. MULTI-AGENT LLM APPROACH VERSUS SINGLE MODEL IN THE MANAGEMENT OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDINGBALABAN H. Y., ŞİMŞEK C., DURAK M. B., ÜÇDAL M.
29. ROLE OF NUCLEAR RECEPTOR COACTIVATOR 4 (NCOA4) GENE VARIANTS IN METABOLIC HYPERFERRITINEMIA OBSERVED IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)BALABAN H. Y., ÜÇDAL M., ŞİMŞEK C., BURUŞ A., ÇELTİKÇİ B.
30. IMPACT OF A SUPERVISED COMBINED EXERCISE PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH MASH: RESULTS FROM A RANDOMIZED CONTROLLED TRIALBALABAN H. Y., KUMBAROĞLU F. B., KARÇAALTINCABA M., PINAR A., KIZIL M., PARLAR Y. E., et al.
31. The role of flow-mediated dilation in assessing cardiovascular risk among patients with non-alcoholic fatty liver disease: A retrospective studyBALABAN H. Y., TOKGÖZOĞLU S. L., AYGÜN S.
32. Fonksiyonel Kabızlıkta Abdominal Masaj ile Birlikte Aerobik Egzersiz Eğitiminin Etkileri: Randomize Kontrollü ÇalışmaDoğan İ. G., ATABEY GERLEGİZ E. N., AKBAYRAK T., BALABAN H. Y., ŞİMŞEK C., ATAY B., et al.
33. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
34. A Comprehensive Study on Gastroenterologists’ Beliefs, Attitudes, And Knowledge of Physical Activity and ExerciseKUMBAROĞLU F. B., DÜGER T., ÖZDEMİR P., BALABAN H. Y.
35. Alkolsüz steatohepatit hastalarında yaşam kalitesi, yorgunluk, duygudurum ve hastalık belirteçleri arasındaki ilişkinin araştırılması.KUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.
36. Wilson Hastalığı Tedavisinde Serum Değişken ve Göreceli Değişken Bakır Testleri 24 Saatlik İdrar Bakır Atılımına Alternatif Olabilir mi?BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., ŞAHİN T., ELİBOL B., DAĞ O.
37. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER CORRELATE WITH MULTIPARAMETRIC LIVER MRI PARAMETERS IN PATIENTS WITH WILSON DISEASEBALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., ŞAHİN T., PINAR A., et al.
38. CAN SERUM EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER BE ALTERNATIVE TESTS TO 24-HOUR URINARY COPPER EXCREATION IN PATIENTS ON TREATMENT FOR WILSON DISEASE?BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PINAR A., ELİBOL B.
39. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER LEVELS WERE SIMILAR IN WILSON DISEASE PATIENTS WITH AND WITHOUT OF CRANIAL MRI INVOLMENTBALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PARLAK Ş., ŞAHİN T., PINAR A., et al.
40. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapyBALABAN H. Y., GÖKCAN H., YAPALI S., AKDOĞAN KAYHAN M., ŞİMŞEK H., İDİLMAN R.
41. Trends and causes of etiology in adult liver transplant patients: multicenter studyBALABAN H. Y., HARPUTLUOĞLU M. M. M., AKYILDIZ N. M., TURAN İ., GÜNŞAR F., KARASU A. Z., et al.
42. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter studyBALABAN H. Y., GÖKCAN H., YAPALI S., GÜZELBULUT F., AKDOĞAN KAYHAN M., KIYICI M., et al.
43. Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experienceTURAN İ., ALADAĞ M., HARPUTLUOĞLU M. M. M., YILMAZ S., GENÇDAL G., POLAT K. Y., et al.
44. Proceedings of the World Congress of GastroenterologyBALABAN H. Y., ASLAN A. T., AKDOĞAN KİTTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
45. Hepatitis B virus screening and immunization rates in special risk groupsŞİMŞEK H., BALABAN H. Y.
46. Hepatitis E virus epidemiology of patients with chronic hepatitis C in TurkeyŞİMŞEK H., BALABAN H. Y.
47. Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.
48. Antiviral ilaç tedavisi alan kronik hepatit B hastalarında Entekavir ve Tenofovir direnç mutasyonlarının araştırılmasıAYDOĞAN S., ERGÜNAY K., BALABAN H. Y., ALP A., ŞİMŞEK H., TATAR G., et al.
49. THE THERAPEUTIC EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON CCL4-INDUCED NECROSIS AND APOPTOSIS IN RAT LIVERKukner A., Tore F., Firat T., Terzi E. H., Oner H., Balaban Y., et al.
50. Kolon Kanserini Taklit Eden Bir Ameboma Vakası Kolonoskopi Cerrahiden Kurtarabilir mi?ŞİMŞEK H., TATAR G., BALABAN H. Y.

1. Kolorektoanal Problemlerde Farmakolojik TedaviBALABAN H. Y., ŞİMŞEK C."Multidisipliner Balış Temeli" ile Pelvik Sağlıkta Fizyoterapi ve Rehabilitasyon, Türkan Albayrak, Serap özgül, Ceren Gürşen, Editör, Hedef Yayıncılık ve Mühendislik, Ankara, ss.249-258, 2023